Torax Medical today announced the release of new data from two leading U.S. medical centers that further establishes the LINX Reflux Management System as a safe and effective procedure for patients suffering from gastroesophageal reflux disease (GERD).
Chronic GERD, when not completely responsive to medical therapy, can progress to serious complications including precancerous Barrett's esophagus and esophageal cancer. Symptoms are often debilitating and may include daily pain, difficulty swallowing and sleep disruption. The disease is also associated with upper respiratory problems including asthma and bronchitis/pneumonia. Medical therapy (acid suppression medications) commonly prescribed to address GERD symptoms do not address the underlying cause of the disease which is a weak sphincter (valve) between the stomach and esophagus.
C. Daniel Smith, MD, Professor of Surgery, Mayo Clinic Jacksonville, Florida recently published his experience with the LINX Magnetic Sphincter Augmentation System in the Journal of the American College of Surgeons. "Our clinical experience with the LINX System matches what has been observed in controlled trials. Importantly, we are seeing LINX as a new treatment option for patients who suffer from GERD despite continuous drug use. The ability to offer patients a minimally invasive treatment which restores their esophageal sphincter without major side effects has been a long-term clinical need which it appears LINX can fulfill," said Dr. Smith.
A second study, recently published in the Annals of Thoracic Surgery presents LINX outcomes by Brian Louie, MD, Director, Thoracic Research and Education and colleagues from the Swedish Cancer Institute and Medical Center in Seattle, Washington. The team evaluated sphincter augmentation with LINX with case matched sphincter reconstruction using the patient's gastric fundus (Nissen fundoplication). Study results demonstrated that both LINX and fundoplication provided significant improvement in GERD symptoms such as heartburn, regurgitation and cough. However, patients implanted with LINX had a greater ability after the procedure to belch and experienced less bloating and gassy feelings, which are commonly associated with laparoscopic Nissen fundoplication surgery.
"The LINX device appears to restore the sphincter barrier function and preserve normal physiology which enables belching and vomiting," said Dr. Brian Louie. "LINX is an important new surgical treatment option for patients who fail medical therapy and have worsening GERD."
The LINX device has been clinically studied for over 7 years. These studies add to the growing body of evidence that the LINX system is an effective and medically necessary treatment in the continuum of care for patients suffering from GERD.
Research uncovers how inhaled house dust mites trigger of allergic asthma